HealSun Biopharm

Company Deals

Hangzhou HealSun Biopharm Secures RMB 200 Million in Series B+ Financing

Fineline Cube Oct 8, 2023

Hangzhou HealSun Biopharm Co., Ltd., a Chinese contract research organization (CRO) and contract development and...

Company Deals

Healsun Biopharm Raises USD 36.7 Million in Series B Financing for Antibody CDMO Expansion

Fineline Cube Aug 19, 2022

China-based Hangzhou Healsun Biopharm Co., Ltd, an antibody and recombinant Contract Development and Manufacturing Organization...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod